Efficacy and safety of the 589/1319 nm solid-state dual-wavelength laser combined with topical benzoyl peroxide for inflammatory acne vulgaris: a split-face randomized controlled trial

被引:0
|
作者
Boonpethkaew, Suphagan [1 ]
Ratanapokasatit, Yanisa [1 ]
Chirasuthat, Sonphet [1 ]
Wattanakrai, Penpun [1 ]
机构
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Dermatol,Dept Med, 270 Rama VI Rd, Bangkok 10400, Thailand
关键词
Acne vulgaris; Acne treatment; Inflammatory acne; 589/1319 nm dual laser; Non-ablative laser; Benzoyl peroxide; PULSED-DYE-LASER; OUTCOMES; UPDATE;
D O I
10.1007/s00403-025-04146-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The 589/1319 nm solid-state dual-wavelength (SSDW) laser, which does not require consumable dye, has the potential to target inflammation and sebum production in acne vulgaris pathogenesis. To assess the efficacy and safety of 598/1319 nm SSDW laser as an adjunctive treatment to conventional treatment, 18 patients with bilateral facial acne, with inflammatory papules or pustules, were recruited. Patients were instructed to apply 2.5% benozoyl peroxide (BPO), the drug for inflammatory acne, to their entire face throughout the study. One side of the face was randomly assigned to receive 4 sessions of 589/1319 nm SSDW laser treatments, administered every 2 weeks. After the last laser treatment, 3 monthly follow-ups were scheduled. Inflammatory lesion count (ILC) and acne-related skin parameters, including hemoglobin level, melanin level, skin depression, and skin roughness were measured. Adverse events (AEs) and patients' satisfaction were assessed. At the 3-month follow-up, the ILC reduced by 46% on the adjunctive laser (BPO + laser) side (p = 0.0080), compared with a 29% reduction on the BPO monotherapy side (p = 0.1875). On the adjunctive laser side, the change in ILC positively correlated with the change in melanin level (r = 0.51, p = 0.0301) and showed a trend towards a positive correlation with the change in depression volume (r = 0.45, p = 0.0606) and roughness level (r = 0.42, p = 0.0806). The patients reported a pain score of 3.4 +/- 2.3 on scale of 10. No serious AEs occurred. Patients' satisfaction scores were higher with the adjunctive laser therapy, although this was not statistically significant (p = 0.2758). In conclusion, the 589/1319 nm SSDW laser provided a synergistic effect as an adjunctive treatment to BPO in inflammatory acne in terms of reducing ILC and improving post inflammatory hyperpigmentation without causing discomfort or downtime.
引用
收藏
页数:10
相关论文
共 21 条
  • [1] Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial
    Choudhury, S.
    Chatterjee, S.
    Sarkar, D. K.
    Dutta, R. N.
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (06) : 628 - 631
  • [2] Efficacy and safety of calcipotriol as a potential topical treatment of acne vulgaris: a randomized, controlled, triple blinded, split-face clinical trial
    Mahran, Ayman
    Ghazally, Alaa
    Ali, Ali Saleh
    Bakr, Radwa M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (04) : 348 - 355
  • [3] Evaluation of the clinical efficacy of the 1450 nm laser in acne vulgaris: a randomized split-face, investigator-blinded clinical trial
    Darne, S.
    Hiscutt, E. L.
    Seukeran, D. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : 1256 - 1262
  • [4] A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris
    Orringer, Jeffrey S.
    Kang, Sewon
    Maier, Lisa
    Johnson, Timothy M.
    Sachs, Dana L.
    Karimipour, Darius J.
    Helfrich, Yolanda R.
    Hamilton, Ted
    Voorhees, John J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (03) : 432 - 438
  • [5] Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy
    Orringer, Jeffrey S.
    Sachs, Dana L.
    Bailey, Evans
    Kang, Sewon
    Hamilton, Ted
    Voorhees, John J.
    JOURNAL OF COSMETIC DERMATOLOGY, 2010, 9 (01) : 28 - 34
  • [6] Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial
    Dreno, B.
    Tan, J.
    Rivier, M.
    Martel, P.
    Bissonnette, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (04) : 737 - 742
  • [7] Treatment of inflammatory acne with a 1450-nm smoothbeam diode laser: a split-face randomized single-blinded controlled trial
    Darne, S.
    Hiscutt, E.
    Seukeran, D. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 106 - 106
  • [8] Efficacy and Safety of Solid-state Dual-wavelength Lasers for the Treatment of Moderate-to-severe Inflammatory Acne in Asian Populations
    Lim, Joyce Teng-Ee
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2024, 12 (01) : E5550
  • [9] A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris
    Gern, Alison
    Walter, Jessica
    Xu, Shuai
    Vakharia, Paras P.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [10] The Efficacy and Safety of Fractional CO2 Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study
    Zhu, Jie
    Ji, Xi
    Li, Min
    Chen, Xiao-e
    Liu, Juan
    Zhang, Jia-an
    Luo, Dan
    Zhou, Bing-rong
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016